Search research articles
Contact Us
Filters
Showing results (21-30 of 36) with videos related to
Page
of 4
Sort By:
The Oncologist
|
March 20, 2021
Clinical Activity and Safety of Cediranib and Olaparib Combination in Patients with Metastatic Pancreatic Ductal Adenocarcinoma without BRCA Mutation
Joseph W Kim, Dana B Cardin, Ulka N Vaishampayan, et al.
JCO Precision Oncology
|
February 27, 2024
Circulating Tumor DNA Dynamics Fail to Predict Efficacy of Poly(ADP-ribose) Polymerase/VEGFR Inhibition in Patients With Heavily Pretreated Advanced Solid Tumors
Yiduo Hu, Azeet Narayan, Yunshan Xu, et al.
JAMA Oncology
|
February 10, 2018
Atezolizumab (MPDL3280A) Monotherapy for Patients With Metastatic Urothelial Cancer: Long-term Outcomes From a Phase 1 Study
Daniel P Petrylak, Thomas Powles, Joaquim Bellmunt, et al.
Urologic Oncology
|
May 21, 2014
Examining the management of muscle-invasive bladder cancer by medical oncologists in the United States
Andrea B Apolo, Joseph W Kim, Bernard H Bochner, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 23, 2018
First-in-Human Phase I Trial of a Tumor-Targeted Cytokine (NHS-IL12) in Subjects with Metastatic Solid Tumors
Julius Strauss, Christopher R Heery, Joseph W Kim, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 16, 2018
CheckMate-032 Study: Efficacy and Safety of Nivolumab and Nivolumab Plus Ipilimumab in Patients With Metastatic Esophagogastric Cancer
Yelena Y Janjigian, Johanna Bendell, Emiliano Calvo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 23, 2019
First-in-Class, First-in-Human Study Evaluating LV305, a Dendritic-Cell Tropic Lentiviral Vector, in Sarcoma and Other Solid Tumors Expressing NY-ESO-1
Neeta Somaiah, Matthew S Block, Joseph W Kim, et al.
Urologic Oncology
|
December 8, 2022
Oncologic outcomes of neoadjuvant chemotherapy in patients with micropapillary variant urothelial carcinoma of the bladder
Syed N Rahman, Soum D Lokeshwar, Jamil S Syed, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 11, 2021
Safety and Clinical Activity of Atezolizumab in Patients with Metastatic Castration-Resistant Prostate Cancer: A Phase I Study
Daniel P Petrylak, Yohann Loriot, David R Shaffer, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
January 23, 2016
Prospective Study Evaluating Na18F PET/CT in Predicting Clinical Outcomes and Survival in Advanced Prostate Cancer
Andrea B Apolo, Liza Lindenberg, Joanna H Shih, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 36) with videos related to
Sort By:
Page
of 4
The Oncologist
|
March 20, 2021
Clinical Activity and Safety of Cediranib and Olaparib Combination in Patients with Metastatic Pancreatic Ductal Adenocarcinoma without BRCA Mutation
Joseph W Kim, Dana B Cardin, Ulka N Vaishampayan, et al.
JCO Precision Oncology
|
February 27, 2024
Circulating Tumor DNA Dynamics Fail to Predict Efficacy of Poly(ADP-ribose) Polymerase/VEGFR Inhibition in Patients With Heavily Pretreated Advanced Solid Tumors
Yiduo Hu, Azeet Narayan, Yunshan Xu, et al.
JAMA Oncology
|
February 10, 2018
Atezolizumab (MPDL3280A) Monotherapy for Patients With Metastatic Urothelial Cancer: Long-term Outcomes From a Phase 1 Study
Daniel P Petrylak, Thomas Powles, Joaquim Bellmunt, et al.
Urologic Oncology
|
May 21, 2014
Examining the management of muscle-invasive bladder cancer by medical oncologists in the United States
Andrea B Apolo, Joseph W Kim, Bernard H Bochner, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 23, 2018
First-in-Human Phase I Trial of a Tumor-Targeted Cytokine (NHS-IL12) in Subjects with Metastatic Solid Tumors
Julius Strauss, Christopher R Heery, Joseph W Kim, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 16, 2018
CheckMate-032 Study: Efficacy and Safety of Nivolumab and Nivolumab Plus Ipilimumab in Patients With Metastatic Esophagogastric Cancer
Yelena Y Janjigian, Johanna Bendell, Emiliano Calvo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 23, 2019
First-in-Class, First-in-Human Study Evaluating LV305, a Dendritic-Cell Tropic Lentiviral Vector, in Sarcoma and Other Solid Tumors Expressing NY-ESO-1
Neeta Somaiah, Matthew S Block, Joseph W Kim, et al.
Urologic Oncology
|
December 8, 2022
Oncologic outcomes of neoadjuvant chemotherapy in patients with micropapillary variant urothelial carcinoma of the bladder
Syed N Rahman, Soum D Lokeshwar, Jamil S Syed, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 11, 2021
Safety and Clinical Activity of Atezolizumab in Patients with Metastatic Castration-Resistant Prostate Cancer: A Phase I Study
Daniel P Petrylak, Yohann Loriot, David R Shaffer, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
January 23, 2016
Prospective Study Evaluating Na18F PET/CT in Predicting Clinical Outcomes and Survival in Advanced Prostate Cancer
Andrea B Apolo, Liza Lindenberg, Joanna H Shih, et al.
Page
of 4